Trials / Terminated
TerminatedNCT01587963
High Dose Vitamin C in the Critically Ill Patient
The Efficacy of High Dose Vitamin C in the Critically Ill Patient Population
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effectiveness of high doses of Vitamin C in critically ill patients.
Detailed description
It has been shown that the stress that occurs during trauma, infection and/or shock depletes many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to further complications. The purpose of this study is to determine the effectiveness of high doses of Vitamin C in critically ill patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ascorbic Acid | 66mg/kg/hour of peripheral intravenous Vitamin C infusion for 24 hour duration, maximum total of 200 grams |
| OTHER | Ringers Lactate or Normal Saline | Fluid resuscitation will be given with NS or LR to achieve a same mean urine output of 0.5cc/kg/hour. |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-02-01
- Completion
- 2015-04-01
- First posted
- 2012-04-30
- Last updated
- 2017-05-11
- Results posted
- 2017-05-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01587963. Inclusion in this directory is not an endorsement.